- Home
- BWLP vs ARQT Comparison
BWLP vs ARQT Comparison
Compare BWLP & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWLP
- ARQT
- Stock Information
- Founded
- BWLP 1935
- ARQT 2016
- Country
- BWLP Singapore
- ARQT United States
- Employees
- BWLP N/A
- ARQT N/A
- Industry
- BWLP Marine Transportation
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- BWLP Consumer Discretionary
- ARQT Health Care
- Exchange
- BWLP Nasdaq
- ARQT Nasdaq
- Market Cap
- BWLP 1.6B
- ARQT 1.7B
- IPO Year
- BWLP N/A
- ARQT 2020
- Fundamental
- Price
- BWLP $14.77
- ARQT $14.77
- Analyst Decision
- BWLP
- ARQT Strong Buy
- Analyst Count
- BWLP 0
- ARQT 7
- Target Price
- BWLP N/A
- ARQT $19.00
- AVG Volume (30 Days)
- BWLP 322.0K
- ARQT 1.7M
- Earning Date
- BWLP 08-27-2025
- ARQT 08-06-2025
- Dividend Yield
- BWLP 11.50%
- ARQT N/A
- EPS Growth
- BWLP N/A
- ARQT N/A
- EPS
- BWLP 1.86
- ARQT N/A
- Revenue
- BWLP $3,387,328,000.00
- ARQT $263,464,999.00
- Revenue This Year
- BWLP N/A
- ARQT $61.83
- Revenue Next Year
- BWLP N/A
- ARQT $36.55
- P/E Ratio
- BWLP $8.72
- ARQT N/A
- Revenue Growth
- BWLP 9.53
- ARQT 99.50
- 52 Week Low
- BWLP $7.86
- ARQT $8.03
- 52 Week High
- BWLP $16.82
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- BWLP 71.35
- ARQT 51.22
- Support Level
- BWLP $14.63
- ARQT $13.97
- Resistance Level
- BWLP $14.93
- ARQT $16.39
- Average True Range (ATR)
- BWLP 0.25
- ARQT 0.81
- MACD
- BWLP 0.07
- ARQT -0.05
- Stochastic Oscillator
- BWLP 82.08
- ARQT 39.89
About BWLP BW LPG Limited Common Shares
BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.